comprehensive -WSS

comprehensive

author：entertainment 2025-09-03 03:36:52 - browse：13768

Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT — Adobe

Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

“A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Listen: PBM conflicts, RSV vaccines, & the future of flu season

knowledge

WSS

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Risky weight loss products often used by teens globally, per study

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

HHS names first

Idaho abortion case may prompt more restrictions in other states

leisure time

comprehensive

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Bacterial infection may be ‘key event’ in endometriosis, study says

Duchenne breakthrough therapy leaves behind pioneering families

Meta looks to target Twitter with a rival app called Threads

Novavax promises a turnaround & Lilly roils the obesity market

A new study asks: Are we harming blood donors by taking blood?

What does generative AI mean for health care? We asked experts

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

At least 13 dead in Texas as scorching temps continue

JPM 2024: Nvidia claims we're in biological revolution. Are we?

focus

A new study asks: Are we harming blood donors by taking blood?

DeSantis can now import cheaper drugs. But will Biden get credit?

Did the public have the right to know Arthur Ashe had AIDS?

Brain 'hot spot' may explain why African Americans feel greater pain

Grail is spending more than ever lobbying Congress

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

entertainment

knowledge

explore

explore